Sensorized T-Shirt Enables Early Discharge After Oncological Urology Surgery
By Lori Solomon HealthDay Reporter
THURSDAY, March 27, 2025 -- A wearable T-shirt monitor can help oncological urology patients return home sooner after robotic-assisted surgery, according to a study presented at the 40th annual European Association of Urology Congress, held from March 21 to 24 in Madrid.
Antonio Pastore, M.D., Ph.D., from the Sapienza University of Rome, and colleagues evaluated early discharge of patients undergoing oncological robotic-assisted urological surgery using remote patient monitoring. The analysis included 70 patients randomly assigned to a wearable, sensorized T-shirt to monitor blood pressure, pulse rate, oxygen saturation, and blood glucose and with discharge 24 to 36 hours earlier, or control.
The researchers reported that mean remote monitoring was 13.5 days and the overall satisfaction rate among patients in the wearable group was 90 percent. Ten percent of patients in the wearable group had trouble understanding the telemedicine-based instructions, while 87 percent found it effective and encouraging. Eight patients in the control group (26 percent) accessed the hospital before their scheduled follow-up versus two patients (6 percent) in the wearable group. In five patients, the T-shirt monitoring detected the onset of cardiological conditions, allowing for early diagnosis and treatment.
“In Italy, where standard discharge time after this type of robotic-assisted urological surgery can be at least 72 hours, being able to allow patients home sooner improves their quality of life as they feel more comfortable in their own environment, and it means we can free up hospital beds, too," Pastore said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Immune Checkpoint Inhibitor Affordability Tied to Widening Survival Disparity
FRIDAY, July 11, 2025 -- The introduction of immune checkpoint inhibitors (ICIs) was associated with a widening survival disparity between those with private insurance and those...
Presurgical Ablative Radiotherapy + Chemo Improves Pathologic Outcomes in Pancreatic Cancer
FRIDAY, July 11, 2025 -- Adding stereotactic ablative radiotherapy (SAbR) to neoadjuvant chemotherapy improves pathologic outcomes for patients diagnosed with pancreatic cancer...
Risk for Severe COVID-19 Elevated for Childhood Cancer Survivors
FRIDAY, July 11, 2025 -- Childhood cancer survivors have a lower risk for registered COVID-19 infection but a higher risk for severe COVID-19, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.